0001415889-21-003585.txt : 20210712
0001415889-21-003585.hdr.sgml : 20210712
20210712160521
ACCESSION NUMBER: 0001415889-21-003585
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210708
FILED AS OF DATE: 20210712
DATE AS OF CHANGE: 20210712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lim Bryant David
CENTRAL INDEX KEY: 0001752888
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 211085590
MAIL ADDRESS:
STREET 1: C/O IDERA PHARMACEUTICALS, INC.
STREET 2: 505 EAGLEVIEW BLVD., SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 4843481600
MAIL ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
4
1
form4-07122021_040706.xml
X0306
4
2021-07-08
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001752888
Lim Bryant David
C/O IDERA PHARMACEUTICALS, INC.
505 EAGLEVIEW BOULEVARD, SUITE 212
EXTON
PA
19341
false
true
false
false
SVP AND GENERAL COUNSEL
Stock Option (Right to Buy)
1.11
2021-07-08
4
A
0
66500
0
A
2031-07-08
Common Stock
66500
66500
D
The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on July 8, 2021. Twenty-five percent (25%) of the stock option vests and becomes exercisable on July 8, 2022 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
/s/ Bryant D. Lim
2021-07-12